Creative Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535M Buy
445,706
+25,071
+6% +$25.6M 0.31% 45
2026
Q1
$387M Buy
420,635
+37,789
+10% +$38.3M 0.26% 48
2025
Q4
$411M Buy
382,846
+29,765
+8% +$28.5M 0.29% 48
2025
Q3
$269M Buy
353,081
+86,089
+32% +$64.1M 0.21% 53
2025
Q2
$208M Buy
266,992
+9,016
+3% +$7.01M 0.18% 62
2025
Q1
$213M Buy
257,976
+22,439
+10% +$18.7M 0.2% 59
2024
Q4
$182M Buy
235,537
+7,011
+3% +$5.81M 0.18% 65
2024
Q3
$202M Sell
228,526
-149
-0.1% -$134K 0.2% 59
2024
Q2
$207M Buy
228,675
+9,007
+4% +$7.2M 0.22% 56
2024
Q1
$171M Buy
219,668
+50,013
+29% +$35.6M 0.19% 59
2023
Q4
$98.9M Buy
169,655
+7,806
+5% +$4.56M 0.18% 72
2023
Q3
$86.9M Buy
161,849
+12,011
+8% +$6.19M 0.12% 86
2023
Q2
$70.3M Sell
149,838
-2,989
-2% -$1.25M 0.09% 96
2023
Q1
$52.5M Sell
152,827
-4,974
-3% -$1.68M 0.08% 112
2022
Q4
$57.7M Buy
157,801
+10,068
+7% +$3.57M 0.09% 105
2022
Q3
$47.8M Sell
147,733
-1,155
-0.8% -$366K 0.08% 98
2022
Q2
$48.3M Buy
148,888
+24,622
+20% +$7.39M 0.08% 107
2022
Q1
$35.6M Buy
124,266
+642
+0.5% +$165K 0.06% 134
2021
Q4
$34.1M Sell
123,624
-6,822
-5% -$1.73M 0.05% 127
2021
Q3
$30.1M Buy
130,446
+11,318
+10% +$2.79M 0.05% 136
2021
Q2
$27.3M Sell
119,128
-249,590
-68% -$50.1M 0.05% 145
2021
Q1
$68.9M Sell
368,718
-3,519
-0.9% -$688K 0.14% 69
2020
Q4
$62.8M Buy
372,237
+23,132
+7% +$3.45M 0.14% 68
2020
Q3
$51.7M Buy
349,105
+4,990
+1% +$772K 0.13% 69
2020
Q2
$56.5M Buy
344,115
+3,139
+0.9% +$482K 0.16% 60
2020
Q1
$47.3M Sell
340,976
-91,787
-21% -$12.6M 0.17% 56
2019
Q4
$56.9M Sell
432,763
-41,106
-9% -$4.76M 0.17% 58
2019
Q3
$53M Sell
473,869
-22,278
-4% -$2.48M 0.17% 59
2019
Q2
$55M Buy
496,147
+58
+0% +$6.83K 0.18% 55
2019
Q1
$64.4M Buy
496,089
+1,045
+0.2% +$127K 0.23% 44
2018
Q4
$57.3M Buy
495,044
+3,731
+0.8% +$417K 0.23% 45
2018
Q3
$52.7M Sell
491,313
-72,300
-13% -$7.23M 0.2% 51
2018
Q2
$48.1M Buy
563,613
+4,455
+0.8% +$366K 0.19% 54
2018
Q1
$43.3M Buy
559,158
+648
+0.1% +$52.2K 0.18% 55
2017
Q4
$47.2M Buy
558,510
+141
+0% +$12K 0.2% 48
2017
Q3
$47.8M Buy
558,369
+4,736
+0.9% +$388K 0.22% 46
2017
Q2
$45.6M Buy
553,633
+474
+0.1% +$38.7K 0.23% 45
2017
Q1
$46.5M Sell
553,159
-12,248
-2% -$981K 0.25% 42
2016
Q4
$41.6M Sell
565,407
-7,204
-1% -$537K 0.25% 45
2016
Q3
$46M Buy
572,611
+497,448
+662% +$39.8M 0.29% 38
2016
Q2
$5.92M Sell
75,163
-649
-0.9% -$48.9K 0.04% 156
2016
Q1
$5.46M Sell
75,812
-381
-0.5% -$28.8K 0.04% 153
2015
Q4
$6.42M Buy
76,193
+7,649
+11% +$635K 0.05% 136
2015
Q3
$5.74M Buy
68,544
+2,291
+3% +$193K 0.05% 145
2015
Q2
$5.53M Buy
66,253
+3,508
+6% +$267K 0.05% 140
2015
Q1
$4.56M Buy
62,745
+1,990
+3% +$142K 0.04% 156
2014
Q4
$4.19M Buy
60,755
+2,868
+5% +$194K 0.04% 157
2014
Q3
$3.75M Buy
57,887
+1,527
+3% +$96.7K 0.04% 156
2014
Q2
$3.5M Buy
56,360
+2,583
+5% +$154K 0.05% 153
2014
Q1
$3.17M Sell
53,777
-7,402
-12% -$413K 0.05% 140
2013
Q4
$3.12M Buy
61,179
+7,938
+15% +$398K 0.05% 134
2013
Q3
$2.68M Buy
53,241
+4,332
+9% +$227K 0.05% 122
2013
Q2
$2.4M Buy
+48,909
New +$2.66M 0.06% 113

Other funds holding LLY

Creative Planning's LLY Position: Q2 2026 in Review

Creative Planning increased its Eli Lilly (LLY) stake by 6% in Q2 2026, buying an estimated $25.6M and bringing the position to 445,706 shares worth $535M. The position accounts for 0.31% of the portfolio, ranked #45.

Creative Planning first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Creative Planning held 445,706 shares of Eli Lilly worth $535M as of Q2 2026.
  • Creative Planning bought 25,071 Eli Lilly shares in Q2 2026, an estimated $25.6M.
  • Eli Lilly made up 0.31% of Creative Planning's portfolio in Q2 2026, its #45 holding.
  • Creative Planning first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.